162 related articles for article (PubMed ID: 36625737)
21. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
[TBL] [Abstract][Full Text] [Related]
22. Coincidental Expression of Classic Hodgkin Lymphoma and Neurofibromatosis Type I and Literature Review.
Cabrera TB; Wang W; Yedururi S; Slopis JM; Steiner RE; Rytting ME; Cuglievan B
J Pediatr Hematol Oncol; 2021 May; 43(4):e535-e538. PubMed ID: 32366782
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of Café-au-lait Macules and their Association with the Neurofibromatosis type I Genotype in a Cohort of Greek Children.
Nasi L; Alexopoulos A; Kokkinou E; Roka K; Tzetis M; Tsipi M; Kakourou T; Kanaka-Gantenbein C; Chrousos G; Kattamis A; Pons R;
Acta Derm Venereol; 2023 Jun; 103():adv5758. PubMed ID: 37272364
[TBL] [Abstract][Full Text] [Related]
24. Jaffe-Campanacci syndrome or neurofibromatosis type 1: a case report of phenotypic overlap with detection of NF1 gene mutation in non-ossifying fibroma.
Vannelli S; Buganza R; Runfola F; Mussinatto I; Andreacchio A; de Sanctis L
Ital J Pediatr; 2020 May; 46(1):58. PubMed ID: 32393377
[TBL] [Abstract][Full Text] [Related]
25. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
26. Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis.
Burkitt Wright EM; Sach E; Sharif S; Quarrell O; Carroll T; Whitehouse RW; Upadhyaya M; Huson SM; Evans DG
J Med Genet; 2013 Sep; 50(9):606-13. PubMed ID: 23812910
[TBL] [Abstract][Full Text] [Related]
27. [Genetic diagnosis of a child with Café-au-lait macules and juvenile xanthogranuloma].
Lu X; Xiao F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1266-1269. PubMed ID: 36317216
[TBL] [Abstract][Full Text] [Related]
28. Choroidal abnormalities in café-au-lait syndromes: a new differential diagnostic tool?
Cassiman C; Casteels I; Jacob J; Plasschaert E; Brems H; Dubron K; Keer KV; Legius E
Clin Genet; 2017 Apr; 91(4):529-535. PubMed ID: 27716896
[TBL] [Abstract][Full Text] [Related]
29. A novel NF1 mutation in a pediatric patient with renal artery aneurysm.
Chillura I; Restivo GA; Callari S; Cibella S; D'Alessandro MM; Corrado C; Vallone M; Antona V; Corsello G
Ital J Pediatr; 2022 Nov; 48(1):186. PubMed ID: 36411470
[TBL] [Abstract][Full Text] [Related]
30. Café au lait spots: When and how to pursue their genetic origins.
Lalor L; Davies OMT; Basel D; Siegel DH
Clin Dermatol; 2020; 38(4):421-431. PubMed ID: 32972601
[TBL] [Abstract][Full Text] [Related]
31. A novel RAB39B mutation and concurrent de novo NF1 mutation in a boy with neurofibromatosis type 1, intellectual disability, and autism: a case report.
Santoro C; Giugliano T; Bernardo P; Palladino F; Torella A; Del Vecchio Blanco F; Onore ME; Carotenuto M; Nigro V; Piluso G
BMC Neurol; 2020 Sep; 20(1):327. PubMed ID: 32873259
[TBL] [Abstract][Full Text] [Related]
32. Genetic evaluation of 50 Turkish patients with neurofibromatosis type 1: 2 years experience of a single center.
Kocabey M; Özkalaycı H; Çankaya T; Yılmaz Uzman C; Çağlayan AO; Ülgenalp A; Erçal MD
Int J Dev Neurosci; 2023 Aug; 83(5):456-465. PubMed ID: 37280783
[TBL] [Abstract][Full Text] [Related]
33. Neurofibromatosis type 1 with overlap Turner syndrome and Klinefelter syndrome.
Hatipoglu N; Kurtoglu S; Kendirci M; Keskin M; Per H
J Trop Pediatr; 2010 Feb; 56(1):69-72. PubMed ID: 19578129
[TBL] [Abstract][Full Text] [Related]
34. Updated Approach to Patients with Multiple Café au Lait Macules.
Albaghdadi M; Thibodeau ML; Lara-Corrales I
Dermatol Clin; 2022 Jan; 40(1):9-23. PubMed ID: 34799039
[TBL] [Abstract][Full Text] [Related]
35. Multiple café au lait macules and Crowe sign.
López Aventín D; Gilaberte M; Pujol RM
Arch Dermatol; 2011 Jun; 147(6):735-40. PubMed ID: 21690543
[No Abstract] [Full Text] [Related]
36. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
Buteică E; Stoicescu I; Burada F; Stănoiu B
Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
[TBL] [Abstract][Full Text] [Related]
37. Identification of a Novel
Xu G; Li M; Niu Y; Huang X; Li Y; Tang G; Long S; Zhao H; Jiang H
Biomed Res Int; 2019; 2019():2721357. PubMed ID: 31886188
[TBL] [Abstract][Full Text] [Related]
38. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
[TBL] [Abstract][Full Text] [Related]
39. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):454-64. PubMed ID: 26979265
[TBL] [Abstract][Full Text] [Related]
40. Mutation spectrum of the NF1 gene and genotype-phenotype correlations in Turkish patients: Seventeen novel pathogenic variants.
Ece Solmaz A; Isik E; Atik T; Ozkinay F; Onay H
Clin Neurol Neurosurg; 2021 Sep; 208():106884. PubMed ID: 34418705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
